Bioavailability of isoflavones from soy products in equol producers and non-producers in Japanese women

Journal of Nutrition and Intermediary Metabolism

Volumn 6, Issue , 2016, Pages 41-47

  Miura, Ayako ^a,b   Sugiyama, Chitose ^b   Sakakibara, Hiroyuki ^c   Simoi, Kayoko ^a   Goda, Toshinao ^a  

^a UNIVERSITY OF SHIZUOKA   (Japan)

^b HAMAMATSU UNIVERSITY   (Japan)

^c UNIVERSITY OF MIYAZAKI   (Japan)

Author keywords

Bioavailability; Equol non producers; Equol producers; Isoflavone; Soy product

Indexed keywords

DAIDZEIN; DRUG METABOLITE; EQUOL; GENISTEIN; ISOFLAVONE DERIVATIVE;

ADULT; ARTICLE; BIOAVAILABILITY; CONTROLLED STUDY; DIETARY SUPPLEMENT; FEMALE; FERMENTED PRODUCT; FOOD INTAKE; HUMAN; HUMAN EXPERIMENT; JAPANESE (PEOPLE); MEAL; NORMAL HUMAN; PRIORITY JOURNAL; RELIABILITY; SOY FOOD; SOYBEAN; SOYBEAN MILK; TOFU; URINARY EXCRETION; URINE SAMPLING;

EID: 84988642808     PISSN: None     EISSN: 23523859     Source Type: Journal    
DOI: 10.1016/j.jnim.2016.08.001     Document Type: Article

References (31)

1. [1] Yamori, Y., Miura, A., Taira, K., Implications from and for food cultures for cardiovascular diseases: Japanese food, particularly Okinawan diets. 2001 Asia Pac J. Clin. Nutr. 10 (2001), 144–145.
2. [2] Yamori, Y., Moriguchi, E.H., Teramoto, T., Miura, A., Fukui, Y., Honda, K.I., Fukui, M., Nara, Y., Taira, K., Moriguchi, Y., Soybean isoflavones reduce postmenopausal bone resorption in female Japanese immigrants in Brazil: a ten-week study. J. Am. Coll. Nutr. 21 (2002), 560–563.
3. [3] Messina, M., Watanabe, S., Setchell, K.D., Report on the 8th international symposium on the role of soy in health promotion and chronic disease prevention and treatment. J. Nutr. 139 (2009), 796S–802S.
4. [4] Hendrich, S., Bioavailability of isoflavones. J. Chromatogr. B 777 (2002), 203–210.
5. [5] IL1, Nielsen, Williamson, G., Review of the factors affecting bioavailability of soy isoflavones in humans. Nutr. Cancer 57 (2007), 1–10.
6. [6] Klejdus, B., Mikelová, R., Petrlová, J., Potesil, D., Adam, V., Stiborová, M., Hodek, P., Vacek, J., Kizek, R., Kubán, V., Evaluation of isoflavone aglycon and glycoside distribution in soy plants and soybeans by fast column high-performance liquid chromatography coupled with a diode-array detector. J. Agric. Food Chem. 27 (2005), 5848–5852.
7. [7] Murphy, P.A., Song, T., Buseman, G., Barua, K., Beecher, G.R., Trainer, D., Holden, J., Isoflavones in retail and institutional soy foods. J. Agric. Food Chem. 47 (1999), 2697–2704.
8. [8] Wang, H.J., Murphy, P.A., Isoflavone content in commercial soybean foods. J. Agric. Food Chem. 42 (1994), 1666–1673.
9. [9] Wang, H., Murphy, P., A. Isoflavone composition of American and Japanese soybeans in Iowa: effects of variety, crop year, and location. J. Agric. Food Chem. 42 (1994), 1674–1677.
10. [10] Day, A.J., DuPont, M.S., Ridley, S., Rhodes, M., Rhodes, M.J., Morgan, M.R., Williamson, G., Deglycosylation of flavonoid and isoflavonoid glycosides by human small intestine and liver beta-glucosidase activity. FEBS Lett. 436 (1998), 71–75.
11. [11] Lampe, J.W., Chang, J.L., Inter individual differences in phytochemical metabolism and disposition. Semin Cancer Biol. 17 (2007), 347–353.
12. [12] Lampe, J.W., Interindividual differences in response to plant-based diets: implications for cancer risk. Am. J. Clin. Nutr. 89 (2009), 1553S–1557S.
13. [13] Lampe, J.W., Is equol the key to the efficacy of soy foods?. Am. J. Clin. Nutr. 89 (2009), 1664S–1667S.
14. [14] Frankenfeld, C.L., Atkinson, C., Thomas, W.K., Goode, E.L., Gonzalez, A., Jokela, T., Wähälä, K., Schwartz, S.M., Li, S.S., et al. Familial correlations, segregation analysis, and nongenetic correlates of soy isoflavone-metabolizing phenotypes. Exp. Biol. Med. (Maywood) 229 (2004), 902–913.
15. [15] Watanabe, S., Yamaguchi, M., Sobue, T., Takahashi, T., Miura, T., Arai, Y., Mazur, W., Wähälä, K., Adlercreutz, H., Pharmacokinetics of soybean isoflavones in plasma, urine and feces of men after ingestion of 60 g baked soybean powder (kinako). J. Nutr., 128, 1998 1710–5.
16. [16] Rowland, I.R., Wiseman, H., Sanders, T.A., Adlercreutz, H., Bowey, E.A., Interindividual variation in metabolism of soy isoflavones and lignans: influence of habitual diet on equol production by the gut microflora. Nutr. Cancer 36 (2000), 27–32.
17. [17] Slavin, J.L., Karr, S.C., Hutchins, A.M., Lampe, J.W., Influence of soybean processing, habitual diet, and soy dose on urinary isoflavonoid excretion. Am. J. Clin. Nutr. 68 (1998), 1492S–1495S.
18. [18] Faughnan, M.S., Hawdon, A., Ah-Singh, E., Brown, J., Millward, D.J., Cassidy, A., Urinary isoflavone kinetics: the effect of age, gender, food matrix and chemical composition. Br. J. Nutr. 91 (2004), 567–574.
19. [19] Cassidy, A., Brown, J.E., Hawdon, A., Faughnan, M.S., King, L.J., Millward, J., Zimmer-Nechemias, L., Wolfe, B., Setchell, K.D., Factors affecting the bioavailability of soy isoflavones in humans after ingestion of physiologically relevant levels from different soy foods. J. Nutr. 136 (2006), 45–51.
20. [20] Chanteranne, B., Branca, F., Kaardinal, A., Wahala, K., Braesco, V., Ladroite, P., Brouns, F., Coxam, V., Food matrix and isoflavones bioavailability in early post menopausal women: a European clinical study. Clin. Interv. Aging 3 (2008), 711–718.
21. [21] Chang, Y., Choue, R., Plasma pharmacokinetics and urinary excretion of isoflavones after ingestion of soy products with different aglycone/glucoside ratios in South Korean women. Nutr. Res. Pract. 7 (2013), 393–399.
22. [22] Sugano, M., Soy in health and disease prevention. Watanabe, S., Zhuo, X.G., Melby, M.K., Ishikawa, N., Kimira, M., (eds.) Systematic review of intervention studies using isoflavone supplements and proposal for future studies, 2006, CRC Press, Taylor & Francis Group, Florida, 87–106.
23. [23] Kimira, Mitsuru, Arai, Yusuke, Shimoi, Kayako, Watanabe, Shaw, Japanese intake of flavonoids and isoflavonoids from foods. J. Epidemiol. 8 (1998), 168–175.
24. [24] Arai, Y., Watanabe, S., Kimira, M., Shimoi, K., Mochizuki, R., Kinae, N., Dietary intakes of flavonols, flavones and isoflavones by Japanese women and the inverse correlation between quercetin intake and plasma LDL cholesterol concentration. J. Nutr. 130 (2000), 2243–2250.
25. [25] Yamamoto, S., Sobue, T., Sasaki, S., Kobayashi, M., Arai, Y., Uehara, M., Adlercreutz, H., Watanabe, S., Takahashi, T., Itoi, Y., Iwase, Y., Akabane, M., Tsugane, S., J. Nutr. 131 (2001), 2741–2747.
26. [26] Sakakibara, H., Viala, D., Ollier, A., Combeau, A., Besle, J.M., Isoflavones in several clover species and in milk from goats fed clovers. Biofactors 22 (2004), 237–239.
27. [27] King, R.A., Mano, M.M., Head, R.J., Assessment of isoflavonoid concentrations in Australian bovine milk samples. J. Dairy Res. 65 (1998), 479–489.
28. [28] Shimoi, K., Okada, H., Furugori, M., Goda, T., Takase, S., Suzuki, M., Hara, Y., Yamamoto, H., Kinae, N., Intestinal absorption of luteolin and luteolin 7-O-beta-glucoside in rats and humans. FEBS Lett. 6 (1998), 220–224.
29. [29] Beaton, G.H., Milner, J., Corey, P., McGuire, V., Cousins, M., Stewart, E., de Ramos, M., Hewitt, D., Grambsch, P.V., Kassim, N., Little, J.A., Sources of variance in 24-hour dietary recall data: implications for nutrition study design and interpretation. Am. J. Clin. Nutr. 32 (1979), 2546–2559.
30. [30] Rosner, B., Fundamentals of biostatistics. 2006, Duxbury Press, CA, 613–617.
31. [31] Vergne, S., Bennetau-Pelissero, C., Lamothe, V., Chantre, P., Potier, M., Asselineau, J., Perez, P., Durand, M., Moore, N., Sauvant, P., Higher bioavailability of isoflavones after a single ingestion of a soya-based supplement than a soya-based food in young healthy males. Br. J. Nutr. 99 (2008), 333–344.